Last reviewed · How we verify
Imipramine Hydrochloride 25 MG — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Imipramine Hydrochloride 25 MG (Imipramine Hydrochloride 25 MG) — Jonatan Kornholt.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Imipramine Hydrochloride 25 MG TARGET | Imipramine Hydrochloride 25 MG | Jonatan Kornholt | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Imipramine Hydrochloride 25 MG CI watch — RSS
- Imipramine Hydrochloride 25 MG CI watch — Atom
- Imipramine Hydrochloride 25 MG CI watch — JSON
- Imipramine Hydrochloride 25 MG alone — RSS
Cite this brief
Drug Landscape (2026). Imipramine Hydrochloride 25 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/imipramine-hydrochloride-25-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab